Validation of the proof of concept using liver biopsy: manufacturers' risk factors of false positive/negative are associated with strength of concordance between Elastography and Biopsy.
收藏NIAID Data Ecosystem2026-03-06 收录
数据链接：
官方服务：
资源简介：
Validation of the proof of concept using liver biopsy: manufacturers' risk factors of false positive/negative are associated with strength of concordance between Elastography and Biopsy.
创建时间：
2008-12-04
